Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

Lancet

Volumn 358, Issue 9299, 2001, Pages 2127-2128

  Valkonen, Veli Pekka ^a   Päivä, Hannu ^d   Salonen, Jukka T ^a,b   Lakka, Timo A ^a   Lehtimäki, Terho ^d   Laakso, Juha ^c   Laaksonen, Reijo ^c,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Inner Savo Health Centre   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR;

ACUTE DISEASE; ADULT; AMINO ACID BLOOD LEVEL; ARTERY ENDOTHELIUM; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FINLAND; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0035936390     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)07184-7     Document Type: Article

References (5)

1. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
2. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia
3. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
4. Low serum lycopene concentration is associated with excess incidence of acute coronary events and stroke: The Kuopio Ischaemic Heart Disease Risk Factor Study
5. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men